The primary care physician: Nephrology interface for the identification and treatment of chronic kidney disease

Journal of Nephrology

Volumn 23, Issue 1, 2010, Pages 23-32

  Stevens, Paul E ^a   Farmer, Christopher K ^a   Hallan, Stein I ^b,c  

^a EAST KENT HOSPITALS UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

Automated estimated GFR reporting; Cardiovascular disease; Chronic kidney disease; Clinical decision support; Screening

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ARTICLE; CHRONIC KIDNEY DISEASE; COST EFFECTIVENESS ANALYSIS; DECISION SUPPORT SYSTEM; DISEASE CLASSIFICATION; EARLY DIAGNOSIS; GLOMERULUS FILTRATION RATE; HEALTH CARE DELIVERY; HIGH RISK POPULATION; HUMAN; INCIDENCE; KIDNEY FAILURE; MASS SCREENING; MEDICAL DECISION MAKING; PATIENT EDUCATION; PATIENT REFERRAL; PRACTICE GUIDELINE; PREVALENCE; PRIMARY MEDICAL CARE; PRIMARY PREVENTION; RISK REDUCTION; UNITED KINGDOM;

CHRONIC DISEASE; DECISION SUPPORT SYSTEMS, MANAGEMENT; DELIVERY OF HEALTH CARE; DISEASE PROGRESSION; GLOMERULAR FILTRATION RATE; GUIDELINES AS TOPIC; HUMANS; KIDNEY DISEASES; NEPHROLOGY; OUTCOME ASSESSMENT (HEALTH CARE); PHYSICIANS, FAMILY; QUALITY OF HEALTH CARE; RISK FACTORS;

EID: 77249127947     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(Suppl 1):S1-S266.
2. Coresh J, Astor BC, Greene T, et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003;41:1-12.
3. Levey AS, Eckhaardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005;67:2089-2100.
4. Chadban SJ, Briganti EM, Kerr PG, et al. Prevalence of kidney damage in Australian adults: the AusDiab kidney study. J Am Soc Nephrol. 2003;14(Suppl 2): S131-S138.
5. Verhave JC, Hillege HL, Burgerhof JG, et al; PREVEND Study Group. The association between atherosclerotic risk factors and renal function in the general population. Kidney Int. 2005;67:1967-1973.
6. Amato D, Varez-Aguilar C, Castaneda-Limones R, et al. Prevalence of chronic kidney disease in an urban Mexican population. Kidney Int. 2005; 97(Suppl):S11-S17.
7. Otero A, Gayoso P, Garcia F, de Francisco AL; on behalf of the EPIRCE study group. Epidemiology of chronic renal disease in the Galician population: results of the pilot Spanish EPIRCE study. Kidney Int. 2005;68(Suppl 99):S16-S19.
8. Hallan SI, Coresh J, Astor BC, et al. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol. 2006;17:2275-2284.
9. Stevens PE, O'Donoghue DJ, de Lusignan S, et al. Chronic kidney disease management in the United Kingdom: NEOERICA project results. Kidney Int. 2007;72:92-99.
10. Imai E, Horio M, Iseki K, et al. Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient. Clin Exp Nephrol. 2007;11:156-163.
11. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038-2047.
12. Zhang L, Zhang P, Wang F, et al. Prevalence and factors associated with CKD: a population study from Beijing. Am J Kidney Dis. 2008;51:373-384.
13. Coresh J, Stevens LA, Levey AS. Chronic kidney disease is common: what do we do next? Nephrol Dial Transplant. 2008;23:1122-1125.
14. Stevens LA, Coresh J, Greene T, et al. Assessing kidney function: measured and estimated glomerular filtration rate. N Eng J Med. 2006;354:2473-2483.
15. Clarke WF, Macnab JJ, Chen SJ, et al. Evaluation of GFR estimating equations in the general community: implications for screening. Clin J Am Soc Nephrol. 2006;1:787-795.
16. Giles PD, Fitzmaurice DA. Formula estimation of glomerular filtration rate: have we gone wrong? BMJ. 2007:334:1198-1200.
17. Glassock RJ, Winearls C. An epidemic of chronic kidney disease: fact or fiction? Nephrol Dial Transplant. 2008;23:1117-1121.
18. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalisation. N Engl J Med. 2004;351:1296-1305.
19. De Jong PE, Gansevoort RT. Fact or fiction of the epidemic of chronic kidney disease: let us not squabble about estimated GFR only, but also focus on albuminuria. Nephrol Dial Transplant. 2008;23:1092-1095.
20. Jafar TH, Stark PC, Schmid CH, et al. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patien-tlevel meta-analysis. Ann Intern Med. 2003;139:244-252.
21. Ruggenenti P, Perna A, Remuzzi G. Retarding progression of chronic renal disease: the neglected issue of proteinuria. Kidney Int. 2003;63:2254-2261.
22. Sarnak MJ, Greene T, Wang X, et al. The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease study. Ann Intern Med. 2005;142:342-351.
23. Wright JT Jr, Bakris G, Greene T, et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA. 2002; 288:2421-2431.
24. Berl T, Hunsicker LG, Lewis JB, et al. Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial. J Am Soc Nephrol. 2005;16:2170-2179.
25. Drey N, Roderick P, Mullee M, et al. A population-based study of the incidence and outcomes of diagnosed chronic kidney disease. Am J Kidney Dis. 2003;42:677-684.
26. John RI, Webb MC, Young A, et al. Unreferred chronic kidney disease: a longitudinal study. Am J Kidney Dis. 2004;43:825-835.
27. Keith DS, Nichols GA, Gullion CM, et al. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med. 2004;164:659-663.
28. Boulware LE, Troll MU, Jaar BG, Myers DI, Powe NR. Identification and referral of patients with progressive CKD: a national study. Am J Kidney Dis. 2006;48:192-204.
29. Lea JP, McClellan WM, Melcher C, Gladstone E, Hostetter T. CKD risk factors reported by primary care physicians: do guidelines make a difference? Am J Kidney Dis. 2006;47:72-77.
30. Fox CH, Brooks A, Zayas LE, McClellan W, Murray B. Primary care physicians' knowledge and practice patterns in the treatment of chronic kidney disease: an Upstate New York Practice-based Research Network (UNYNET) study. J Am Board Fam Med. 2006;19:54-61.
31. Nickolas TL, Frisch GD, Opotowsky AR, Arons R, Radha-krishnan J. Awareness of kidney disease in the US population: findings from the National Health and Nutrition Examination Survey (NHANES) 1999 to 2000. Am J Kidney Dis. 2004;44:185-197.
32. Coresh J, Byrd-Holt D, Astor BC, et al. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol. 2005;16:180-188.
33. Jurkovitz C, Franch H, Shoham D, Bellenger J, McClellan W. Family members of patients treated for ESRD have high rates of undetected kidney disease. Am J Kidney Dis. 2002;40:1173-1178.
34. Smith JM, Mott SA, Hoy WE. Status of chronic kidney disease prevention programs: International Federation of Kidney Foundation Members 2005/2007. Kidney Int. 2008;74:1516-1525.
35. Hoy WE, Baker PR, Kelly AM, Wang Z. Reducing premature death and renal failure in Australian Aboriginals: a community-based cardiovascular and renal protective program. Med J Aust. 2001;174:201-202.
36. Hoy WE, Wang Z, Baker PR, Kelly AM. Reduction in natural death and renal failure from a systematic screening and treatment program in an Australian Aboriginal community. Kidney Int. 2003;63:S66-S73.
37. Hoy WE, Kondalsamy-Chennakesavan S, Scheppingen-Smith J, Sharma S, Katz I. A chronic disease outreach program for Aboriginal communities. Kidney Int. 2005; 68:S76-S82.
38. Katz I, Hoy WE, Kondalsamy-Chennakesavan S, et al. Chronic kidney disease management: what can we learn from South African and Australian efforts? Blood Purif. 2006;24:115-122.
39. Mathew TH. Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: a position statement. Med J Aust. 2005;183:138-141.
40. National Kidney Foundation. KEEP: Kidney Early Evaluation Program. New York: National Kidney Foundation; 2009. Available at: http://www.kidney.org/ news/keep/index.cfm. Accessed December 20, 2009.
41. Hostetter TH, Lising M. National Kidney Disease Education Program. J Natl Med Assoc. 2002;94(8 Suppl):72S-75S.
42. Imai E, Yamagata K, Iseki K, et al. Kidney disease screening program in Japan: history, outcome, and perspectives. Clin J Am Soc Nephrol. 2007;2:1360-1366.
43. Iseki K. Chronic kidney disease in Japan. Intern Med. 2008;47:681-689.
44. UK Department of Health. National Service Framework for Renal Services: Part Two: chronic kidney disease, acute renal failure and end of life care. UK Department of Health; 2005. Available at: www.dh.gov.uk/renal.
45. NHS Connecting for Health. PMIP weekly status report. UK National Health Service; 2007. Available at: http://www.connectingforhealth.nhs.uk/ systemsandservices/pathology/edifact/pmip/reports. Accessed December 20, 2009.
46. The Information Centre for Health and Social Care. The Quality and Outcomes Framework. UK National Health Service; 2009. Available at:http://www.ic.nhs.uk/statistics-and-datacollections/audits-and-performance/ the-quality-and-outcomes-framework. Accessed December 20, 2009.
47. Putting Prevention First: vascular checks: risk assessment and management. UK Department of Health. Available at: http://www.dh.gov.uk/en/ Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH-083822. Accessed February 15, 2009.
48. Joint Specialty Committee for Renal Disease Royal College of Physicians of London and the Renal Association. Chronic kidney disease in adults: UK guidelines for identification, management and referral. London: Royal College of Physicians of London; 2006. Available at: http://www.renal.org/CKDguide/ckd. html. Accessed December 20, 2009.
49. Burden R, Tomson C. Identification, management, and referral of adults with chronic kidney disease: concise guidelines. Clin Med. 2005;5:635-642.
50. The Renal Association. The short CKD eGuide, derived from the UK CKD Guidelines (2005). Revised 2009. Available at: http://www.renal.org/eGFR/eguide. html. Accessed December 20, 2009.
51. Archibald G, Bartlett W, Brown A, et al. UK consensus conference on early chronic kidney disease, 6 and 7 February 2007. Nephrol Dial Transplant. 2007;22:2455-2457.
52. Clinical Resource Efficiency Support Team. Guidelines for chronic kidney disease in Northern Ireland. Belfast: CREST Secretariat; 2006. Available at: www.crestni.org.uk/chronic-kidney-disease-guidelines.pdf. Accessed December 20, 2009.
53. Caring for Australasians with Renal Impairment (CARI). Prevention of progression of chronic kidney disease guidelines. Available at: http://www.cari.org.au/guidelines.php. Accessed December 20, 2009.
54. Diagnosis and management of chronic kidney disease: a national clinical guideline. Available at: http://www.sign.ac.uk/pdf/sign103.pdf. Accessed February 15, 2009.
55. National Institute for Health and Clinical Excellence. Early identification and management of chronic kidney disease in adults in primary and secondary care. Available at: http://www.nice.org.uk/Guidance/CG73. Accessed December 20,2009.
56. Accetta NA, Gladstone EH, DiSogra C, Wright EC, Briggs M, Narva AS. Prevalence of estimated GFR reporting among US clinical laboratories. Am J Kidney Dis. 2008;52:778-787.
57. UK Department of Health. Estimated glomerular filtration rate (eGFR). Available at: http://www.dh.gov.uk/en/Healthcare/NationalServiceFrameworks/ Renal/RenalInformation/DH-4133073. Accessed December 20, 2009.
58. Noble E, Johnson DW, Gray N, et al. The impact of automated eGFR reporting and education on nephrology service referrals. Nephrol Dial Transplant. 2008;23:3845-3850.
59. Torregrosa I, Solis M, Pascual B, et al. Implementation of a nephrology-primary health care joint protocol for the management of chronic renal disease: preliminary results. Nefrologia. 2007;27:162-167.
60. Aghaie-Jaladerany H, Cowell D, Geddes CC. The early impact of the United Kingdom chronic kidney disease (CKD) guidelines on the number of new attendances at renal clinics. Scott Med J. 2007;52:28-31.
61. Wyatt C, Konduri V, Eng J, Rohatgi R. Reporting of estimated GFR in the primary care clinic. Am J Kidney Dis. 2007;49:634-641.
62. Renal Health Care Committee. Results of the National Renal Healthcare Program in Uruguay. Renal Health Care Committee 2004-2007. Available at: http://www.nefrouruguay.com/content/mazzuchi.pdf. Accessed February 15, 2009.
63. Fox CH, Swanson A, Kahn LS, Glaser K, Murray BM. Improving chronic kidney disease care in primary care practices: an Upstate New York Practice-based Research Network (UNYNET) study. J Am Board Fam Med. 2008;21:522-530.
64. Cortés-Sanabria L, Cabrera-Pivaral CE, Cueto-Manzano AM, et al. Improving care of patients with diabetes and CKD: a pilot study for a cluster-randomized trial. Am J Kidney Dis. 2008;51:777-788.
65. Richards N, Harris K, Whitfield M, et al. Primary care-based disease management of chronic kidney disease (CKD), based on estimated glomerular filtration rate (eGFR) reporting, improves patient outcomes. Nephrol Dial Transplant. 2008;23:549-555.
66. Klebe B, Irving J, Stevens PE, et al. The cost of implementing UK guidelines for the management of chronic kidney disease. Nephrol Dial Transplant. 2007;22:2504-2512.